Q32 Bio Inc.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
financial.report
Occurred
2025-12-31
Reported
2026-03-10
Disclosure lag
69 days

Context

links are based on the recorded entity type
FieldRecorded value
EntityQ32 Bio Inc.
SourceSEC EDGAR
Source identifiercompanyfacts/CIK0001661998/2026-07-26
Event ID#29086

Recorded payload

JSON payload as stored after parsing
{
  "accession": "0001193125-26-099339",
  "canonical_covered": 11,
  "canonical_total": 12,
  "fiscal_period": "FY",
  "fiscal_year": 2025,
  "form": "10-K",
  "mapped_tag_share": 0.047021943573667714,
  "metrics": {
    "cash_and_equivalents": 48297000,
    "earnings_per_share_basic": 2.42,
    "earnings_per_share_diluted": 2.42,
    "net_income": 29821000,
    "operating_cash_flow": -33543000,
    "operating_income": 16902000,
    "revenue": 53737000,
    "shareholders_equity": 42014000,
    "shares_outstanding": 12858047,
    "total_assets": 61776000,
    "total_liabilities": 19762000
  },
  "metrics_reported": 11,
  "period_end": "2025-12-31"
}

Source: SEC EDGAR · as of 2026-03-10T00:00:00Z

Q32 Bio Inc. — recorded event — Tapewire